(Date:1/8/2009)...re/ -- Amira Pharmaceuticals, a small molecule pha...arly development of compounds to treat inflammator... Paul Anderson, Professor Jerold Chun and Professo...his further strengthens the Board that includes Pr... Inflammatory diseases, Harvard Medical School ),...
(Date:1/8/2009)...ire/ -- Sonoma is known for delicious food, great,... also be known for inventive,beef recipes. The 2... in late,September, during the peak of the area,s...k competition and a Chef/Media Challenge. Home co... chefs working in the San Francisco Bay Area,and ...
(Date:1/8/2009)...Newswire-USNewswire/ -- Visitors to this year,s Pe...u shots and other helpful resources by stopping at..., , "Pennsylvania,s flu season got off to a rela...he rise. Getting a flu shot now is the best way to...ss," said acting Secretary of Health Everette Jame...
(Date:1/8/2009)...and can lead to severe depression yet pain is wid...ded as ,normal, in later life. Now a new study fro...le,s experiences of pain and how best Government, ...ssue. , The report, Pain in older people: refle...pective , aims to highlight the issue of pain in o...
Breaking Medicine News(10 mins):Health News:Amira Pharmaceuticals, Inc. Expands its Scientific Advisory Board and Appoints Dr. Paul Anderson, Professor Jerold Chun and Professor Andrew Tager 2Health News:Amira Pharmaceuticals, Inc. Expands its Scientific Advisory Board and Appoints Dr. Paul Anderson, Professor Jerold Chun and Professor Andrew Tager 3Health News:28th National Beef Cook-Off(R) Seeks 'Sonoma-Style' Recipe Entries 2Health News:28th National Beef Cook-Off(R) Seeks 'Sonoma-Style' Recipe Entries 3Health News:A life with pain -- new study examines the experiences of older people 2Health News:A life with pain -- new study examines the experiences of older people 3Health News:A life with pain -- new study examines the experiences of older people 4...tive tooth at some point of their life. A visit to...n out' or 'you brush in a hard way, so your teeth ...versity have come out with a solution that could m...researchers have developed a solution which they c...
...IVF) baby of a single parent has been born in a ci...egal status and the single father's parenthood rig...ad ended in divorce years ago, is apparently the c...r whose son was born through IVF method this Sunda...
...tal imaging focus on modalities such as (MRI). The...abies and newborns with MR imaging that uses no io...ment of many // disorders that were previously und...etal MRI is usually performed when ultrasound is i...
... have found a new combination drug for combating P... causing malaria. They used a combination of Chlor...lling P. falciparum which is resistant to Chloroqu...d drug in the treatment of malaria since 1950s. Ch...
Other Medicine News:Health News:A first for India - IVF baby born of surrogacy 2(Date:1/8/2009)...n to be Quark,s second indication with clinical-st...date , , FREMONT, Calif., Jan. 8 /PRNewswire/ ...e pharmaceutical company discovering and developin..., today announced that it has initiated patient do...ts systemically administered siRNA drug candidate ...
(Date:1/8/2009)...entify and Validate Novel Gene Expression Biomarke...Expression Platform , , FREMONT, Calif., Jan. 8...c. (OTC Bulletin Board: WGBS), a leading developer...cell biology and stem cell research systems, today... with the University of Texas Southwestern Medica...
(Date:1/8/2009)...PRNewswire/ -- If you are taking prescription medi...e. Half of the people taking,prescription medicin...ried -- they forget, are busy with other prioritie...ance has been called the Achilles heel of modern,... commented, "Drugs don,t,work in people who don,t...
(Date:1/8/2009)...COLUMBUS, Ohio, Jan. 8 IntelligentM...leic acid assays, today announced that verificatio...ive Assay are complete. , , Under the verifica...pecificity and reproducibility and robustness of t...e data obtain agreed with internally generated ana...
Breaking Medicine Technology:Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function 2Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function 3Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function 4WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 2WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 3WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 4WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 5Good Medicine: Smarter Smartphones for People With Chronic Disease 2Verification Studies of IntelligentMDx's Proprietary Molecular Diagnostic Assay Process Have Been Completed 2Verification Studies of IntelligentMDx's Proprietary Molecular Diagnostic Assay Process Have Been Completed 3Ascension Orthopedics Launches the TITAN 28TM 29 Humeral Resurfacing Device World Wide 10497 1Systems biologist finds novel solutions to fundamental biological problems 2059 1Systems biologist finds novel solutions to fundamental biological problems 2059 2Kiwa Bio Tech Animal Feed Volume Increased 25 25 in Fourth Quarter of 2007 2856 1Kiwa Bio Tech Animal Feed Volume Increased 25 25 in Fourth Quarter of 2007 2856 2Stryker to Host Analyst Meeting 10493 1Stryker to Host Analyst Meeting 10493 2... Results Published in the Journal of Clinical Onco...all/ -- Results from a,Phase II study - which will...Journal of Clinical Oncology (JCO) and are now,ava...blank" href=,"http://www.jco.org/">www.jco.org - ...bb Company investigational,compound, has activity ...
... -- (MARKET WIRE) -- July 06, 2007 -- DOR BioPharm...tudio.financialcontent.com/Engine?Account=iwire&am...studio.financialcontent.com/Engine?Account=iwire&a...r the "Company") announced today that the European..., with claims related to,oral vaccination using mu...
Other Medicine Technology:Study Shows Ixabepilone Demonstrated Clear Activity in Patients,with Metastatic Breast Cancer Resistant to Anthracycline, Taxane,and Capecitabine 2Study Shows Ixabepilone Demonstrated Clear Activity in Patients,with Metastatic Breast Cancer Resistant to Anthracycline, Taxane,and Capecitabine 3Study Shows Ixabepilone Demonstrated Clear Activity in Patients,with Metastatic Breast Cancer Resistant to Anthracycline, Taxane,and Capecitabine 4DOR BioPharma Announces Issuance of European Patent for Its Oral,Multivalent Botulinum Toxin Vaccine BT-VACC 2DOR BioPharma Announces Issuance of European Patent for Its Oral,Multivalent Botulinum Toxin Vaccine BT-VACC 3DOR BioPharma Announces Issuance of European Patent for Its Oral,Multivalent Botulinum Toxin Vaccine BT-VACC 4DOR BioPharma Announces Issuance of European Patent for Its Oral,Multivalent Botulinum Toxin Vaccine BT-VACC 5DOR BioPharma Announces Issuance of European Patent for Its Oral,Multivalent Botulinum Toxin Vaccine BT-VACC 6Each handle is designed to fit a specific trephine size.
Reusable, stainless steel trephine with handle.
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons.
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons.
Medicine Products: